Skip to main content
. Author manuscript; available in PMC: 2013 Aug 7.
Published in final edited form as: Liver Transpl. 2011 May;17(5):528–538. doi: 10.1002/lt.22271

Figure 3.

Figure 3

Virological responses in prophylaxis patients and in observation patients who switched to treatment (the ITT population). RVR was defined as undetectable HCV RNA after 4 weeks of treatment, cEVR was defined as undetectable HCV RNA after 12 weeks of treatment, and SVR was defined as undetectable HCV RNA 24 weeks after the end of treatment. *Before receiving any study medication, 1 prophylaxis patient withdrew consent.